In addition to blocking the inhibitory signal, anti-LLT1 mAb may activate ADCC (antibody dependent cell mediated cytotoxicity) function of NK cell against breast cancer and prostate cancer [Figure 1]. The gene discussed is CLEC2D; the disease is Familial prostate cancer.